Browse > Article

EFFECTS OF LOCAL IRRIGATION AND/OR INTRAVENOUS ADMINISTRATION OF ARGATROBAN ON THROMBOSIS IN MICROVASCULAR ANASTOMOSES OF FEMORAL VEIN OF RABBIT  

Kook, Min-Suk (Department of Oral and Maxillofacial Surgery, School of Dentistry, Dental Science Research Institute, Chonnam National University)
Park, Hong-Ju (Department of Oral and Maxillofacial Surgery, School of Dentistry, Dental Science Research Institute, Chonnam National University)
Oh, Hee-Kyun (Department of Oral and Maxillofacial Surgery, School of Dentistry, Dental Science Research Institute, Chonnam National University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.31, no.4, 2005 , pp. 300-305 More about this Journal
Abstract
Purpose: For the reconstruction of maxillofacial defect created by trauma, infection, or tumor etc, the role of microvascular anastomosis or vessel graft has been increased. Many methods has been tried to increase the success rate of microvascular anastomosis. Various anticoagulants and thrombolytic agents have been used to reduce the failure rate of microvascular anastomosis and avoid re-operation. Many drugs, however, have been used in the limited cases because most of these drugs may cause complications, such as allergy, fever or systemic bleeding. This study was performed to evaluate the influence of the Argatroban on patency and thrombosis in microvascular anastomosis when it is used for local irrigation or general administration. Materials & methods: Eight mature rabbits, weighing 2kg, were used. After exposing both femoral veins, the artificial thrombotic model was made by crushing injury using a smooth needle holder, and the transverse incision were made on femoral vein. The animals were divided into 4 groups according to Argatroban administration methods; control group (n=4), topical irrigation of lumen with saline solution; experimental group 1 (n=4), topical irrigation of lumen with Argatroban saline solution; experimental group 2 (n=4), topical irrigation of lumen with heparin followed by intravenous injection of Argatroban; experimental group 3 (n=4), topical irrigation of lumen with Argatroban followed by IV of Argatroban. Microvascular anastomosis was done with 10-0 Ethilon. The patency was evaluated by empty-and-refill test 30 minutes and 3 days after microanastomosis. The thrombus formation was examined 3 days after microanastomosis by surgical microscope. The histologic findings were also examined. Results: 1. Thirty minutes after microvascular anastomosis, the patency of all experimental groups was better than that of control group, but there was no significant difference among groups. 2. Three days after microvascular anastomosis, the patency of all experimental groups was more improved than that of control group (p<0.05). There was no significant difference among experimental groups. 3. Three days after microvascular anastomosis, the amount of thrombus in all experimental groups was less than that of control group (p<0.05). There was no significant difference among experimental groups. 4. Histologically, a lot of luminal thrombus was observed around sutured area in control group. Few luminal thrombus was observed in all experimental groups. The necrotic changes were observed on the sutured vein wall in all specimens. Conclusion: These results indicate that topical irrigation and/or intravenous administration of Argatroban is effective in improving patency and preventing thrombus formation after microvascular anastomosis.
Keywords
Argatroban; Local irrigation; Intravenous administration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Okamoto S, Hijikata A, Kikumoto R, Tonomura S, Hara H, Ninomiya K: Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun 1981;101:440-446   DOI   ScienceOn
2 Fareed J, Jeske WP: Small-molecule direct antithrombins: Argatroban. Best Pract Res Clin Haematol 2004;17:127-138   DOI   PUBMED   ScienceOn
3 Swan SK, Hursting MJ: The pharmacokinetics and pharmacodynamics of Argatroban. Pharm 2000;20:318-329
4 Haimovici H., Hoffert PW, Sinicola N: An experimental and clinical evaluation of grafts in the venous system. Surg Gyencol Obstet 1970;131:1173-1186
5 Lewis BE, Wallis DE, Hursting MJ, Kelton JG: Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 2003;163:1849-1856   DOI   ScienceOn
6 Li X, Cooley BC, Gould JS: Influence of topical induced thrombosis of microvascular anastomoses. Microsurg 1992;13:72-75   DOI   ScienceOn
7 Greenberg BM, Masem M, Wang YX, Rubin P, May JW: Efficacy of intraarterial heparin in maintaining microvascular patency; An experimental model. Plast Reconstr Surg 1991;87:933-940   DOI   ScienceOn
8 Fu K, Izquierdo R, Hubbard T, Fareed J: Modified crush-avulsion anastomosis model on the rat femoral vein. Microsurg 1995;16:536-541   DOI   ScienceOn
9 Brais M, Bertranous E, Brassard A, Stanley P, Chartrand C: Effect of dextran on patency of pericardial tubular grafts of the superior vena cava in the dog. J Thorac Cardiovasc Surg 1973;65:296-303
10 Lord JW, Rossi G: Mesocaval shunt modified by the case of a Teflon prosthesis. Surg Gynecol Obstet 1970;130:525-526
11 Yamada K, Tsuji H, Kimura S, Kato H: Effects of Argatroban and heparin on thrombus formation and tissue plasminogen activatorinduced thrombolysis in a microvascular thrombosis model. Thromb Res 2003;109:55-64   DOI   ScienceOn
12 Nagasue N, Ogawa Y, Yukata H, Hirose S: Modified distal splenorenal shunt with expanded polytetrafluoroethylene interposition. Surg 1985;98:870-877
13 Haimovici H, Zinicola N, Noorani M, Hoffert PW: Vein grafts in the venous system. Arch Surg 1963;87:542-547   DOI   ScienceOn
14 Acland R: Prevention of thrombosis in microvascular surgery by the use of magnesium sulphate. Br J Plast Surg 1972;25:292-299   DOI   PUBMED   ScienceOn
15 Warkentin TE: Current agents for the treatment of patients with heparin-induced thrombocytopenia. Current Opinion in Pul Med 2002;8:405-412   DOI   ScienceOn
16 Hergrueter CA, Handren J, Kersh R, May JW Jr: Human recombinant tissue type plasminogen activator and its effect on microvascular thrombosis in the rabbit. Plast Reconstr Surg 1988;81:418-424   DOI   ScienceOn
17 Hijikata-Okunomiya A, Okamoto S, Wanaka K: Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III. Thromb Res 1990;59:976-977
18 Lunven C, Gauffeny C, Lecoffre C, O'Brien DP, Roome NO, Berry CN: Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin. Thromb Haemost 1996;75:154-160
19 Holt MH, Lewis FJ: Experimental grafts of the superior vena cava with temporary arteriovenous shunts. J Thorac Cardiovasc Surg 1965;49:818-823
20 Collins HA, Burrus G, Debakey ME: Experimental evaluation of grafts in the canine inferior vena cava. Am J Surg 1960;99:40-44   DOI   ScienceOn
21 Friedman EW, Hamilton AJ: Polytetrafluoroethylene grafts in the peripheral venous circulation of rabbits. Am J Surg 1983;146:355-359   DOI   ScienceOn
22 Fujiwara Y, Cohn LH, Adams D, Collins JJ: Use of Goretex grafts for replacement of the superior and inferior venae cavae. Thorac Cardiovasc Surg 1974;67:774-779
23 Scherck JP, Kerstein MD, Stansel HC: The current status of vena caval replacement. Surg 1974;76:209-233
24 Dale W, Scott HW: Grafts of the venous system. Surg 1963;53:52-73
25 Ross R, Vogel A: The platelet-dervied growth factor. Cell 1978;14:203-210   DOI   ScienceOn
26 Todd RS, Sive EB, Dejode LR, Danese C, Howard JM: Replacement of segments of the venous system. Arch Surg 1963;87:998-1002   DOI   ScienceOn
27 Valji K, Arun K, Bookstein JJ: Use of a direct thrombin inhibitor (Argatroban) during pulse-spray thrombolysis in experimental animals. J Vasc Int Radiol 1995;6:91-95   DOI   ScienceOn
28 Hudson DA, Engelbrecht G, Duminy FJ: Another method to prevent venous thrombosis in microsurgery; An in situ venous catheter. Plast Reconstr Surg 2000;105:999-1003   DOI   ScienceOn